Hyposmia and Cognitive Impairment in Gaucher Disease Patients and Carriers

  title={Hyposmia and Cognitive Impairment in Gaucher Disease Patients and Carriers},
  author={A. McNeill and Raquel Dur{\'a}n and C. Proukakis and J. Br{\'a}s and D. Hughes and A. Mehta and J. Hardy and N. Wood and A. Schapira},
  journal={Movement disorders : official journal of the Movement Disorder Society},
  pages={526 - 532}
  • A. McNeill, Raquel Durán, +6 authors A. Schapira
  • Published 2012
  • Psychology, Medicine
  • Movement disorders : official journal of the Movement Disorder Society
  • The objective of this study was to assess a cohort of Gaucher disease patients and their heterozygous carrier relatives for potential clinical signs of early neurodegeneration. Gaucher disease patients (n = 30), heterozygous glucocerebrosidase mutation carriers (n = 30), and mutation‐negative controls matched by age, sex, and ethnicity (n = 30) were recruited. Assessment was done for olfactory function (University of Pennsylvania Smell Identification Test), cognitive function (Mini‐Mental State… CONTINUE READING
    Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers
    • 3
    • Highly Influenced
    • Open Access
    Clinical, genetic, and brain sonographic features related to Parkinson’s disease in Gaucher disease
    • 16
    • Open Access
    Are There Neurological Symptoms in Type 1 of Gaucher Disease?


    Publications referenced by this paper.
    Idiopathic hyposmia as a preclinical sign of Parkinson's disease
    • 631
    • Open Access
    The risk of Parkinson’s disease in type 1 Gaucher disease
    • 133
    • Highly Influential
    • Open Access
    The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.
    • 99
    • Highly Influential
    • Open Access